NYXH Nyxoah SA
0.8222USD0.7480 EUR · EBR-6.38%Mkt Cap: 83.73M USDP/E: —1d ago
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.…